Australia
Pope Leo XIV's writings verified by Proudly Human
MELBOURNE, Australia and ROME , July 21, 2026 /PRNewswire/ -- Proudly Human has today announced thatMaps of Hope, a collection of speeches and writings by Pope Leo XIV on education and artificial intelligence, has been verified as human-authored, carrying the ProudlyHuman™ trust mark. In the sam...
Sungrow Opens Australia's New Solar & Battery Experience Hub, Bringing the Future of Clean Energy Closer to Home
SUNSHINE COAST, Australia, July 21, 2026 /PRNewswire/ -- Sungrow, the globally leading PV inverter and energy storage system provider, officially opened its brand new Solar & Battery Experience Hub, marking a significant milestone in the company's long-term investment in the Australian renewable ...
Fox ESS Launches POWER BEAST to Simplify C&I Energy Storage Deployment
SYDNEY, July 21, 2026 /PRNewswire/ -- Fox ESS, a global leader in renewable
energy solutions, has announced the Australian launch ofPOWER BEAST, a scalable
commercial and industrial energy storage solution combining theH3 Plus Hybrid
Inverter with the CQ7 High Voltage Storage Battery.
Telix Q2 Revenue US$247M, Strong Momentum and Pipeline Progress
MELBOURNE, Australia and INDIANAPOLIS, July 21, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") provides a market update on its commercial and operational performance for the quarter ended June 30, 2026 (Q2 2026). Q2 2026 Highlights[1] * Group revenue of US...
Granicus Strengthens ANZ Leadership Team with Appointment of Jonathan Usher as Managing Director
Latest leadership appointments reinforce Granicus' commitment to "growth, innovation and customer success" across Australia and New Zealand MELBOURNE, Australia, July 21, 2026 /PRNewswire/ -- Granicus, a leading provider of customer experience technologies and services for governments and destin...
Telix Doses First Patient in Phase 3 LUTEON Trial of TLX250-Tx for Renal Cancer
• First patient dosed in Phase 3 LUTEON[1] trial evaluating TLX250-Tx in relapsed or recurrent clear cell renal cell carcinoma (ccRCC). • LUTEON is the first Phase 3 study of a CAIX[2]-targeted radiopharmaceutical therapy in ccRCC MELBOURNE, Australia and INDIANAPOLIS, July 21, 2026 /PRNewswire...
Ascentium Welcomes MGI Dobbyn Carafa, Strengthening Advisory Capability in Australia
MELBOURNE, Australia, July 20, 2026 /PRNewswire/ -- Ascentium
Moore Global's Strongest Growth Lies Ahead, Says New CEO Vivienne Muir
LONDON, July 20, 2026 /PRNewswire/ -- Moore Global today announced the
appointment of Vivienne Muir as Chief Executive Officer, as the global
accounting and advisory network enters its next phase of growth and
international development.
Chocolate Master Ryan Stevenson named as official Callebaut Ambassador in South Pacific, Australia.
Internationally acclaimed Chocolatier to lead Callebaut's renewed engagement with the chocolate and pastry community across Australia and New Zealand MELBOURNE, Australia, July 20, 2026 /PRNewswire/ -- Internationally recognised Australian Pastry Chef and Chocolatier Ryan Stevenson, has been app...
Emergent Raises Series C at $1.5 Billion Valuation, Becomes Unicorn in a Year of Launch
Rapid global adoption fuels fivefold valuation growth, taking total funding to
$230 million as users build over 12 million applications on the platform
SAN FRANCISCO, Calif. and BANGALORE, India, July 17, 2026 /PRNewswire/ --
Emergent
AGIBOT Brings APC 2026 to Australia and New Zealand, Building a Professional Partner Ecosystem to Accelerate Local Deployment of Embodied AI
MELBOURNE, Australia, July 17, 2026 /PRNewswire/ -- AGIBOT, a global leader in embodied AI and robotics, hosted the Australia and New Zealand AGIBOT Partner Conference (APC) 2026 in Melbourne, marking an important step in AGIBOT's long-term commitment to supporting local partners, customers and e...
DIMERIX EXPANDS PIPELINE WITH ACQUISITION OF PHASE 2 READY ASSET FOR ACUTE KIDNEY INJURY
Highlights * Dimerix acquires Phase 2-ready asset, DMX-652 - with potential for rapid advancement into a Phase 2 clinical study under an open US Investigational New Drug (IND) application, with initial focus on acute kidney injury (AKI) * DMX-652 offers potential to address a significant unme...
HEALEY ALS Platform Trial Regimen I enrolment completed - Topline results for NUZ-001 accelerated to Q2 CY2027
* 250 participants enrolled in less than five months from first participant dosing, representing the fastest site activation and enrolment in the HEALEY ALS Platform Trial so far * Anticipated topline efficacy and safety results for NUZ-001 now expected in late Q2 CY2027 * Completion of rec...
Telix Completes Patient Enrollment in TLX591-Px (Illuccix®) Japan Phase 3 Study
* Completed enrollment of 105 patients in Phase 3 registration study of TLX591-Px (Illuccix®) for prostate cancer imaging in Japan. * The study data will be used to support a New Drug Application (NDA) for TLX591-Px in Japan. MELBOURNE, Australia and TOKYO, July 17, 2026 /PRNewswire/ -- Telix...
Bluestaq Launches BLUESTAQ / ARQ in Australia
Architecture Proven in Allied Operations Now Available to Australian Commercial, Government, and Enterprise Organisations Eight years of architecture built for the most demanding environments on the planet. Now available to every organisation with the same problem. CANBERRA, Australia, July 16, ...
New research reveals loyalty crisis as only 15% of consumers say brand marketing feels relevant - Dotdigital launches AI-powered loyalty platform to help marketers fight back
LONDON, July 16, 2026 /PRNewswire/ -- New global research of 4,000 consumers finds loyalty programmes now rank among the biggest drivers of repeat purchases, while personalisation remains a major blind spot for brands. Consumers are becoming increasingly selective about the brands they stay loya...
Enfinity Global Partners with Strioga Family Foundation to Advance 150 MW Energy Storage Project in Italy
MILAN, July 16, 2026 /PRNewswire/ -- Enfinity Global, a leading renewable energy company, and E Energy Invest, the investment vehicle of the Strioga Family Foundation, today announced a strategic co-investment partnership in Italy. Under the agreement, Strioga Family Foundation will acquire a 49...
FXTRADING.com Becomes FXT, Built Around a Simple Promise: In Control. When It Gets Real.
SYDNEY, July 16, 2026 /PRNewswire/ -- FXTRADING.com has rebranded to FXT, introducing a new brand platform, "In Control. When Things Get Real," built around a single idea: traders cannot control the market, but they must be able to trust their platform. FXTRADINGing.com in now FXT The new bra...
Telix Opens Australian-First Facility to Accelerate Delivery of New Cancer Treatments and Expand Sovereign Manufacturing
* First-of-its-kind facility in Australia where radiopharmaceuticals are developed, manufactured and administered to patients under one roof. * Patient care and research delivered in collaboration with the Melbourne Theranostic Innovation Centre (MTIC), led by its world-class clinical research...
First Patients Dosed in OPTIMAL-e Trial for Earlier Stage Prostate Cancer
* First patients dosed in OPTIMAL-e[1] Phase 2 study evaluating TLX597-Tx for metastatic hormone-sensitive prostate cancer at St Vincent's Hospital Sydney. * OPTIMAL-e will evaluate TLX597-Tx in earlier prostate cancer treatment setting, building on the OPTIMAL-PSMA[2] study which recently com...
Week's Top Stories
Most Reposted
Franchising & Licensing Asia 2026 Opens New Chapter Under MP, Strengthening Singapore's Position as Asia's Franchise and Licensing Hub
[Picked up by 309 media titles]
2026-07-30 10:45J.P. Morgan Private Bank Earns Record 10 Accolades at The Asset Triple A Private Capital Awards 2026
[Picked up by 294 media titles]
2026-07-30 15:00KC Global Media announces new travel series "AXN Ultimate Challenge: Sarawak"
[Picked up by 292 media titles]
2026-07-30 09:12Articura Launches a New Chapter for Sovereign Healthcare AI in Indonesia
[Picked up by 291 media titles]
2026-07-27 19:02ADA acquires Algonomy, strengthening its intelligent growth platform for a fully agentic experience
[Picked up by 290 media titles]
2026-07-30 15:30